Genetic and molecular mechanisms of pulmonary hypertension

Clinical Medicine

Volumn 1, Issue 2, 2001, Pages 138-145

  Morrell, N W ^a   Wilkins, M R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANOXIA; GENETICS; HUMAN; MALE; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; RAT; REVIEW;

ANIMALS; ANOXIA; HUMANS; HYPERTENSION, PULMONARY; MALE; RATS;

EID: 0035291426     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.1-2-138     Document Type: Article

References (66)

1. Hughes JMB. Distribution of pulmonary blood flow. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds). The lung: scientific foundations. Philadelphia: Lippincott-Raven, 1997:1523-36.
2. von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946;12:301-20.
3. Morrell NW, Nijran KS, Biggs T, Seed WA. Regional matching of ventilation and perfusion during lobar bronchial obstruction in man. Clin Sci 1995;88:179-84.
4. Boutilier RG, Glass ML, Heisler N. The relative distribution of pulmocutaneous blood flow in Rana catesbeiana: effects of pulmonary or cutaneous hypoxia. J Exp Biol 1986;126:33-9.
5. Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 1976;57: 542-54.
6. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979;236:H818-27.
7. Heath D. Pulmonary vascular disease. In: Hasleton PS (ed). Spencer's pathology of the lung. London: McGraw-Hill, 1996:649-93.
8. Weir EK, Tucker A, Reeves JT, Will DH, Grover RF. The genetic factor influencing pulmonary hypertension in cattle at high altitude. Cardiovasc Res 1974;8:745-9.
9. Cruz JC, Reeves JT, Russell BE, Alexander AF, Will DH. Embryo transplanted calves: the pulmonary hypertensive trait is genetically transmitted. Proc Soc Exp Biol Med 1980;164:142-5.
10. Langleben D, Jones RC, Aronovitz MJ, Hill NS, et al. Pulmonary artery structural changes in two colonies of rats with different sensitivity to chronic hypoxia. Am J Pathol 1987;128:61-6.
11. Sato K, Webb S, Tucker A, Rabinovitch M, et al Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 1992;145:793-7.
12. Wilkins MR, Zhao L, Al-Tubuly R. The regulation of pulmonary vascular tone. Br J Clin Pharmac 1996;42:127-31.
13. Aguirre JI, Morrell NW, Long L, Clift P, et al. Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia. Am J Physiol 2000;278:L981-7.
14. Zhao L, Sebkhi A, Nunez DJ, Long L, et al Right ventricular hypertrophy secondary to pulmonary hypertension is linked to rat chromosome 17: evaluation of cardiac ryanodine Ryr2 receptor as a candidate. Circulation 2001;103:442-7.
15. Vogel HJK, Weaver WF, Rose LD. Pulmonary hypertension on exertion in normal man living at 10,150 feet (Leadville, Colorado). In: Grover RF (ed). Normal and abnormal pulmonary circulation. Basel: S. Karger, 1963:289-91.
16. Reeves JT, Durmowicz AG. High altitude and the pulmonary circulation. In: Peacock AJ (ed). Pulmonary circulation: a handbook for physicians. London: Chapman and Hall, 1996:262-72.
17. Groves B, Droma T, Sutton JR, McCullough RG, et al. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658m. J Appl Physiol 1993;74:312-8.
18. Morrell NW, Sarybaev AS, Alikhan A, Mirrakhimov MM, Aldashev A. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 1999;353:814.
19. Madden JA, Vadula MS, Kurup VP. Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am J Physiol 1992;263:L384-93.
20. McMurtry IF, Davidson AB, Reeves JT, Grover RF. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 1976;38:99-104.
21. Weir EK, Reeve HL, Cornfield DN, Tristani FM, et al. Diversity of response in vascular smooth muscle cells to changes in oxygen tension. Kidney Int 1997;51:462-6.
22. Weir EK, Reeve HL, Peterson DA, Michelakis ED, Nelson DP, Archer SL. Pulmonary vasoconstriction, oxygen sensing, and the role of ion channels: Thomas A. Neff lecture. Chest 1998;114(1 Suppl):17S-22S.
23. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a wide-spread oxygen sensing mechanism. Proc Nat Acad Sci USA 1993;90: 2423-7.
24. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993;90:4304-8.
25. Ratcliffe PJ. Hypoxically inducible gene expression. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds). The lung: scientific foundations. Philadelphia: Lippincott-Raven, 1997:319-32.
26. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. Activation of hypoxia-inducible factor-1;definition of regulatory domains within the à subunit. J Biol Chem 1997;272:11205-14.
27. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-7.
28. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991;114:464-9.
29. Zamora MA, Dempsey EC, Walchak SJ, Stelzner TJ. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 1993;9:429-33.
30. Morrell NW, Upton PD, Kotecha S, Huntley A, et al. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth msucle via AT1 receptors. Am J Physiol 1999;277:L440-8.
31. Morrell NW, Atochina EN, Morris KG, Danilov SG, Stenmark KR. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995;96:1823-33.
32. Morrell NW, Danilov SM, Satyan KB, Morris KG, Stenmark KR. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension. Cardiovasc Res 1997;34:393-403.
33. Fagan KA, Fouty BW, Tyler RC, Morris KG, et al. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 1999;103:291-9.
34. Zhao L, Long L, Morrell NW, Wilkins MR. NPR-A-deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 1999;99:605-7.
35. Rubin LJ. Primary pulmonary hypertension. New Engl J Med 1997;336:111-7.
36. Pietra GG, Edwards WD, Kay JM, Rich S, et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 1989;80:1198-1206.
37. Palevsky HI, Schloo B, Pietra GG, Weber KT, et al Primary pulmonary hypertension: vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation 1989;80:1207-21.
38. Cool CD, Stewart JS, Werahera P, Miller GJ, et al Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Am J Pathol 1999;155:411-9.
39. Lee S-D, Shroyer KR, Markham NE, Cool CD, et al Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101:927-34.
40. Abenhaim L, Moride Y, Brenot F, Rich S, et al Appetite-suppressant drugs and the risk of primary pulmonary hypertension. New Engl J Med 1996;335:609-16.
41. Polak J, Oakley CM, Yacoub M, Mikhail G, Taylor-Robinson SD. Primary pulmonary hypertension: pathologist as patient. J R Coll Physicians Lond 1998;32:225-30.
42. Haworth SG. Primary pulmonary hypertension. J R Coll Physicians Lond 1998;32:187-90.
43. Dresdale DT, Michtom RJ, Schultz M. Recent studies in primary pulmonary hypertension including pharmacodynamic observations on pulmonary vascular resistance. Bull N Y Acad Sci 1954;30:195-207.
44. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
45. Elliot G, Alexander G, Leppert M, Yeates S, Kerber R. Coancestry in apparently sporadic primary pulmonary hypertension. Chest 1995; 108:973-7.
46. Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 1984;129:194-7.
47. Morse JH, Jones AC, Barst RJ, Hodge SE, et al. Familial primary pulmonary hypertension locus mapped to chromosome 2q31-q32. Chest 1998;114(1 Suppl):57S-58S.
48. Nicholls WC, Koller DL, Slovis B, Foroud T, et al. Localisation of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nature Genet 1997;15:277-80.
49. The International PPH Consortium, Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germ-line mutations in BMPR2, encoding a TGF-â receptor, cause familial primary pulmonary hypertension. Nature Genet 2000;26:81-4.
50. Deng Z, Morse JH, Slager SL, Cuervo N, et al. Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67: 737-44.
51. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family. J Med Genet 2000;37:741-5.
52. Kawabata M, Imamura T, Miyazano K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 1998;9:49-61.
53. Rosenzweig BL, Imamura T, Okadome T, Cox GN, et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 1995;92:7632-6.
54. Massague J, Chen Y-G. Controlling TGF-β signaling. Genes Dev 2000; 14:627-44.
55. Raftery LA, Sutherland DJ. TGF-β family signal transduction in Drosophila development: from Mad to Smads. Dev Biol 1999;210: 251-68.
56. Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997;61:68-79.
57. Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nature Genet 1994;6:205-9.
58. McCaffrey TA, TGF-βs and TGF-β receptors in atherosclerosis. Cytokine Growth Factor Rev 2000;11:103-14.
59. Dorai H, Vukizevic S, Sampath TK. Bone morphogenetic protein-7 (OP-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 2000;184:37-45.
60. Nakaoka T, Go ida K, Ogita T, Otawara-Hamamoto Y, et al. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 1997;100:2824-32.
61. Lu SL, Kawabata M, Imamura T, Akiyama Y, et al. HNPCC associated with germline mutation in the TGF beta type II receptor gene [letter]. Nature Genet 1998;19:17-8.
62. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994;121:409-15.
63. Langleben D, Barst RJ, Badesch D, Groves BM, et al. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. Circulation 1999;99:3266-71.
64. Wharton J, Davie N, Upton PD, Yacoub MH, et al. Prostacyclin analogues differentially inhibit the growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 2000;102:3130-6.
65. Morrell NW, Morris KG, Stenmark KR. Role of angiotensin converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995;269:H1186-94.
66. Orte C, Polak JM, Haworth SG, Yacoub MH, Morrell NW. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 2000;192: 379-84.